These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6413678)

  • 1. Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems.
    Chien YW; Keshary PR; Huang YC; Sarpotdar PP
    J Pharm Sci; 1983 Aug; 72(8):968-70. PubMed ID: 6413678
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system.
    Karim A
    Angiology; 1983 Jan; 34(1):11-22. PubMed ID: 6401951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin.
    Higo N; Hinz RS; Lau DT; Benet LZ; Guy RH
    Pharm Res; 1992 Feb; 9(2):187-90. PubMed ID: 1553339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of nitroglycerin ointments in the rabbit.
    Ritschel WA; Ritschel-Beurlin G; Grummich K
    Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site dependence for topical absorption of nitroglycerin in rats.
    Horhota ST; Fung HL
    J Pharm Sci; 1978 Sep; 67(9):1345-6. PubMed ID: 99511
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparisons of in vitro nitroglycerin (TNG) flux across yucatan pig, hairless mouse, and human skins.
    Roberts ME; Mueller KR
    Pharm Res; 1990 Jun; 7(6):673-6. PubMed ID: 2114619
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis, disposition and pharmacokinetics of nitroglycerin.
    Curry SH; Aburawi SM
    Biopharm Drug Dispos; 1985; 6(3):235-80. PubMed ID: 3929851
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol: water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin.
    Berner B; Mazzenga GC; Otte JH; Steffens RJ; Juang RH; Ebert CD
    J Pharm Sci; 1989 May; 78(5):402-7. PubMed ID: 2501473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Taylor SH
    Lancet; 1984 Jul; 2(8394):97. PubMed ID: 6146027
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu W
    Lancet; 1984 Jun; 1(8389):1297. PubMed ID: 6145002
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.
    Nakashima E; Noonan PK; Benet LZ
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):423-37. PubMed ID: 3119815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transdermal application of nitroglycerin in the treatment of angina pectoris].
    Koster RW
    Ned Tijdschr Geneeskd; 1985 Dec; 129(50):2389-90. PubMed ID: 3937062
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans.
    Sved S; McLean WM; McGilveray IJ
    J Pharm Sci; 1981 Dec; 70(12):1368-9. PubMed ID: 6798193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal nitroglycerin ointment and patches.
    Todd B
    Geriatr Nurs; 1986; 7(3):152-4. PubMed ID: 3084347
    [No Abstract]   [Full Text] [Related]  

  • 19. Transmucosal controlled-release nitroglycerin.
    Med Lett Drugs Ther; 1987 Apr; 29(737):39-40. PubMed ID: 3104737
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of vehicle additives on the transdermal delivery of nitroglycerin.
    Loftsson T; Gildersleeve N; Bodor N
    Pharm Res; 1987 Oct; 4(5):436-7. PubMed ID: 3150045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.